140 related articles for article (PubMed ID: 8896401)
21. Effects of recombinant thrombopoietin on the growth of murine primitive and committed hematopoietic progenitors in serum-free culture.
Sasaki H; Ikuta K; Funabiki T; Fujioka K; Matsuda M
Pediatr Int; 1999 Dec; 41(6):666-72. PubMed ID: 10618888
[TBL] [Abstract][Full Text] [Related]
22. Do the preclinical effects of thrombopoietin correlate with its in vitro properties?
Kaushansky K; Broudy VC; Sitnicka E; Lofton-Day C; Grossmann A; Sprugel K
Stem Cells; 1996; 14 Suppl 1():108-11. PubMed ID: 11012209
[TBL] [Abstract][Full Text] [Related]
23. Contrasting effects of recombinant human granulocyte-macrophage colony-stimulating factor (CSF) and granulocyte CSF treatment on the cycling of blood elements in childhood-onset cyclic neutropenia.
Wright DG; Kenney RF; Oette DH; LaRussa VF; Boxer LA; Malech HL
Blood; 1994 Aug; 84(4):1257-67. PubMed ID: 7519479
[TBL] [Abstract][Full Text] [Related]
24. Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice.
Moore MA; Warren DJ
Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7134-8. PubMed ID: 3499607
[TBL] [Abstract][Full Text] [Related]
25. Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice.
Kaushansky K; Lin N; Grossmann A; Humes J; Sprugel KH; Broudy VC
Exp Hematol; 1996 Feb; 24(2):265-9. PubMed ID: 8641351
[TBL] [Abstract][Full Text] [Related]
26. Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.
Winter JN; Lazarus HM; Rademaker A; Villa M; Mangan C; Tallman M; Jahnke L; Gordon L; Newman S; Byrd K; Cooper BW; Horvath N; Crum E; Stadtmauer EA; Conklin E; Bauman A; Martin J; Goolsby C; Gerson SL; Bender J; O'Gorman M
J Clin Oncol; 1996 Jan; 14(1):277-86. PubMed ID: 8558209
[TBL] [Abstract][Full Text] [Related]
27. Thrombopoietin: biology and clinical potentials.
Miyazaki H; Kato T
Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
[TBL] [Abstract][Full Text] [Related]
28. Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization.
Gajewski JL; Rondon G; Donato ML; Anderlini P; Korbling M; Ippoliti C; Benyunes M; Miller LL; LaTemple D; Jones D; Ashby M; Hellmann S; Durett A; Lauppe J; Geisler D; Khouri IF; Giralt SA; Andersson B; Ueno NT; Champlin R
Biol Blood Marrow Transplant; 2002; 8(10):550-6. PubMed ID: 12434950
[TBL] [Abstract][Full Text] [Related]
29. In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons enhanced circulation of progenitor cells.
Andrews RG; Briddell RA; Knitter GH; Opie T; Bronsden M; Myerson D; Appelbaum FR; McNiece IK
Blood; 1994 Aug; 84(3):800-10. PubMed ID: 7519077
[TBL] [Abstract][Full Text] [Related]
30. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.
Peters WP; Rosner G; Ross M; Vredenburgh J; Meisenberg B; Gilbert C; Kurtzberg J
Blood; 1993 Apr; 81(7):1709-19. PubMed ID: 7681699
[TBL] [Abstract][Full Text] [Related]
31. Flt3 ligand and thrombopoietin serum levels during peripheral blood stem cell mobilization with chemotherapy and recombinant human glycosylated granulocyte colony-stimulating factor (rhu-G-CSF, lenograstim) and after high-dose chemotherapy.
Bojko P; Pawloski D; Stellberg W; Schröder JK; Seeber S
Ann Hematol; 2002 Sep; 81(9):522-8. PubMed ID: 12373354
[TBL] [Abstract][Full Text] [Related]
32. Accelerated reconstitution of platelets and erythrocytes after syngeneic transplantation of bone marrow cells derived from thrombopoietin pretreated donor mice.
Fibbe WE; Heemskerk DP; Laterveer L; Pruijt JF; Foster D; Kaushansky K; Willemze R
Blood; 1995 Nov; 86(9):3308-13. PubMed ID: 7579432
[TBL] [Abstract][Full Text] [Related]
33. Systemic effects of pegylated recombinant human megakaryocyte growth and development factor in combination with recombinant murine granulocyte colony-stimulating factor in a murine model of myelosuppression.
Coleman D; Fairchild D; Schindler-Horvat J; Munyakazi L; Neumann TA
Toxicol Sci; 1998 Sep; 45(1):77-87. PubMed ID: 9848114
[TBL] [Abstract][Full Text] [Related]
34. Combination therapy for radiation-induced bone marrow aplasia in nonhuman primates using synthokine SC-55494 and recombinant human granulocyte colony-stimulating factor.
MacVittie TJ; Farese AM; Herodin F; Grab LB; Baum CM; McKearn JP
Blood; 1996 May; 87(10):4129-35. PubMed ID: 8639770
[TBL] [Abstract][Full Text] [Related]
35. Further examination of various administration protocols of pegylated recombinant human megakaryocyte growth and development factor on thrombocytopenia in myelosuppressed mice.
Akahori H; Ozai M; Ida M; Shibuya K; Kato T; Miyazaki H
Ther Apher; 1998 Feb; 2(1):58-64. PubMed ID: 10227790
[TBL] [Abstract][Full Text] [Related]
36. Recombinant human thrombopoietin improves the efficacy of intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor in mobilizing peripheral blood stem cells in patients with multiple myeloma: A cohort study.
Wang G; Chen W; Wu Y; Li Y; Leng Y; Liu A
Medicine (Baltimore); 2017 Dec; 96(50):e9302. PubMed ID: 29390394
[TBL] [Abstract][Full Text] [Related]
37. Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin.
Brugger W; Birken R; Bertz H; Hecht T; Pressler K; Frisch J; Schulz G; Mertelsmann R; Kanz L
Br J Haematol; 1993 Jul; 84(3):402-7. PubMed ID: 7692928
[TBL] [Abstract][Full Text] [Related]
38. Effects of combined administration of interleukin-6 and granulocyte colony-stimulating factor on recovery from radiation-induced hemopoietic aplasia.
Patchen ML; Fischer R; MacVittie TJ
Exp Hematol; 1993 Feb; 21(2):338-44. PubMed ID: 7678816
[TBL] [Abstract][Full Text] [Related]
39. Abnormal responses of myeloid progenitor cells to recombinant human colony-stimulating factors in congenital neutropenia.
Kobayashi M; Yumiba C; Kawaguchi Y; Tanaka Y; Ueda K; Komazawa Y; Okada K
Blood; 1990 Jun; 75(11):2143-9. PubMed ID: 1693298
[TBL] [Abstract][Full Text] [Related]
40. Thrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferation.
Ferrajoli A; Talpaz M; Kurzrock R; Harris D; Van Q; Estey EH; Estrov Z
Leuk Lymphoma; 1998 Jul; 30(3-4):279-92. PubMed ID: 9713960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
